Therapy Areas: Oncology
Profusa launches Lumee tissue oxygen system for CRO market
16 January 2026 - US-based digital health company Profusa, Inc. (NASDAQ: PFSA), which develops tissue-integrated biosensors for continuous biochemical monitoring, announced on Friday the launch of a h...
OncoHost receives BIG Innovation Award in Health category
16 January 2026 - OncoHost, a technology company focused on precision medicine, announced on Monday that the Business Intelligence Group has named OncoHost as a winner in the 2026 BIG Innovation Award...
Hoth Therapeutics achieves European regulatory milestone for HT-001
16 January 2026 - Hoth Therapeutics Inc (NASDAQ:HOTH), a US-based clinical-stage biopharmaceutical company, announced on Thursday that it has achieved a major European regulatory milestone for its HT-...
Zydus Lifesciences acquires Agenus Inc's biologics manufacturing facilities, launches Zylidac Bio LLC in US
16 January 2026 - Zydus Lifesciences Limited, an India-based life-sciences company, announced on Thursday that it has completed an Asset Purchase Agreement, Share Purchase Agreement, and exclusive Lic...
AVEO Oncology reports first patient dosed in front-line AML combination study of ficlatuzumab
15 January 2026 - US-based AVEO Oncology, an LG Chem (KRX:051910) company, announced on Wednesday that the first patient has been successfully dosed in a Phase 1b/2 clinical trial evaluating ficlatuzu...
GenomOncology and OHSU Knight Diagnostics Lab partner to enhance clinical trial matching for cancer patients
15 January 2026 - Precision medicine reporting solutions company GenomOncology (GO) announced on Wednesday that it has formed a strategic partnership with Oregon Health & Science University's...